Medworxx Solutions Inc. Announces Shareholder Approval of Plan of Arrangement

TORONTO, ONTARIO--(Marketwired - Oct. 8, 2015) - Medworxx Solutions Inc. (TSX VENTURE:MWX) ("Medworxx"), is pleased to announce that Medworxx shareholders have approved the previously announced plan of arrangement (the "Arrangement") involving Medworxx and an affiliate of Aptean, Inc. ("Aptean").

At the special meeting of Medworxx shareholders held earlier today, the Arrangement was approved by approximately 99.97% of the votes cast by shareholders of Medworxx represented in person or by proxy at the special meeting. In accordance with Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions, the Arrangement was also approved by approximately 99.96% of the votes cast at the meeting by disinterested shareholders.

The completion of the Arrangement remains subject to the approval of the Superior Court of Ontario. The hearing is to be held at 330 University Avenue, 8^th Floor, Toronto, Ontario on October 13, 2015 at or about 10:00 a.m. If approved and all other conditions to the Arrangement are satisfied, Aptean will acquire all of the outstanding class A common shares of Medworxx and Medworxx will become a wholly-owned subsidiary of Aptean.

The class A common shares of Medworxx are expected to be delisted from the TSX Venture Exchange (the "Exchange") at the close of trading on or about two business days after the closing of the Arrangement.

Closing of the Arrangement is expected to occur on or about October 14, 2015.

Further information regarding the Arrangement may be found in the management information circular of Medworxx dated September 9, 2015 prepared in connection with the special meeting of Medworxx shareholders and which is available under Medworxx's profile at www.sedar.com.

About Medworxx

Medworxx delivers health information solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges and requirements in compliance and education. Medworxx Clinical Criteria- flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components - currently serves over 34% of the acute care beds in Canada. Founded in 2004, Medworxx is based in Toronto, Ontario and publicly traded on the TSX Venture Exchange: MWX. Visit: www.medworxx.com.